Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Genomic medicine must reduce, not compound, health inequities: the case for hauora-enhancing genomic resources for New Zealand.

Robertson SP, Hindmarsh JH, Berry S, Cameron VA, Cox MP, Dewes O, Doughty RN, Gray G, Jacobsen JC, Laurence A, Matisoo-Smith E, Morton S, Shelling AN, Sika-Paotonu D, Rolleston A, Skinner JR, Snell RG, Sporle A, Print C, Merriman TR, Hudson M, Wilcox P.

N Z Med J. 2018 Aug 17;131(1480):81-89.

PMID:
30116069
2.

Engaging Postgraduate Students Undertaking Clinical Pharmacology Using GoSoapBox for Problem-Based Learning.

Sika-Paotonu D, Robinson B, Maling T.

J Nurs Educ. 2017 Sep 1;56(9):575-576. doi: 10.3928/01484834-20170817-14. No abstract available.

PMID:
28876448
3.

Acute Rheumatic Fever and Rheumatic Heart Disease.

Sika-Paotonu D, Beaton A, Raghu A, Steer A, Carapetis J.

In: Ferretti JJ, Stevens DL, Fischetti VA, editors. Streptococcus pyogenes : Basic Biology to Clinical Manifestations [Internet]. Oklahoma City (OK): University of Oklahoma Health Sciences Center; 2016-.
2017 Mar 10 [updated 2017 Apr 3].

4.

Grading of clear cell renal cell carcinoma should be based on nucleolar prominence.

Delahunt B, Sika-Paotonu D, Bethwaite PB, William Jordan T, Magi-Galluzzi C, Zhou M, Samaratunga H, Srigley JR.

Am J Surg Pathol. 2011 Aug;35(8):1134-9. doi: 10.1097/PAS.0b013e318220697f.

PMID:
21716085
5.

Exploiting the role of endogenous lymphoid-resident dendritic cells in the priming of NKT cells and CD8+ T cells to dendritic cell-based vaccines.

Petersen TR, Sika-Paotonu D, Knight DA, Simkins HM, Hermans IF.

PLoS One. 2011 Mar 31;6(3):e17657. doi: 10.1371/journal.pone.0017657.

6.

Re: Fuhrman grade provides higher prognostic accuracy than nucleolar grade for papillary renal cell carcinoma: T. Klatte, C. Anterasian, J. W. Said, M. de Martino, F. F. Kabbinavar, A. S. Belldegrun and A. J. Pantuck J Urol 2010; 183: 2143-2147.

Delahunt B, Bethwaite PB, Miller RJ, Sika-Paotonu D, Srigley JR.

J Urol. 2011 Jan;185(1):356-7; author reply 357-8. doi: 10.1016/j.juro.2010.08.045. Epub 2010 Nov 20. No abstract available.

PMID:
21094961
7.

Potent anti-tumor responses to immunization with dendritic cells loaded with tumor tissue and an NKT cell ligand.

Petersen TR, Sika-Paotonu D, Knight DA, Dickgreber N, Farrand KJ, Ronchese F, Hermans IF.

Immunol Cell Biol. 2010 Jul;88(5):596-604. doi: 10.1038/icb.2010.9. Epub 2010 Feb 9.

PMID:
20142835
8.

Fuhrman grading is not appropriate for chromophobe renal cell carcinoma.

Delahunt B, Sika-Paotonu D, Bethwaite PB, McCredie MR, Martignoni G, Eble JN, Jordan TW.

Am J Surg Pathol. 2007 Jun;31(6):957-60.

PMID:
17527087
9.

Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma.

Sika-Paotonu D, Bethwaite PB, McCredie MR, William Jordan T, Delahunt B.

Am J Surg Pathol. 2006 Sep;30(9):1091-6.

PMID:
16931953

Supplemental Content

Loading ...
Support Center